AMCP 2022: RWE Research Keeps Coming on Strong, Say JMCP Editor-in-Chief

April 01, 2022

Real-world studies are increasing as real-world data for new drugs for cancer and autoimmune disease have “matured,” says Laura E. Happe, Pharm.D., M.P.H., the editor-in-chief of Journal of Managed Care and Specialty Pharmacy.

AMCP 2022: High Out-of-Pocket Costs Are Associated with Nonadherence Among Patients Taking Oral Cancer Drugs

March 31, 2022

“Popping a pill” makes cancer treatment more convenient, but research presented at the AMCP annual meetings shows that almost half of cancer patients on oral therapies are nonadherent. Oral administration typically moves a drug to the pharmacy benefit, which can mean high out-of-pocket costs and, in turn, nonadherence.

AMCP 2022: Prevalence of Alopecia Areata Is Increasing

March 31, 2022

Using a claims database, researchers found a steady increase in the prevalence of alopecia areata from 2016 to 2019 among those with employer-based health insurance. They also found a higher prevalence and incidence rate among women than among men.